ILC1 Confer Early Host Protection at Initial Sites of Viral Infection.

TitleILC1 Confer Early Host Protection at Initial Sites of Viral Infection.
Publication TypeJournal Article
Year of Publication2017
AuthorsWeizman O-E, Adams NM, Schuster IS, Krishna C, Pritykin Y, Lau C, Degli-Esposti MA, Leslie CS, Sun JC, O'Sullivan TE
JournalCell
Volume171
Issue4
Pagination795-808.e12
Date Published2017 Nov 02
ISSN1097-4172
KeywordsAnimals, Herpesviridae Infections, Immunity, Innate, Immunologic Surveillance, Inflammation, Interferon-gamma, Killer Cells, Natural, Liver, Lymphocytes, Mice, Inbred C57BL, Muromegalovirus, Peritoneal Cavity, Virus Replication
Abstract

Infection is restrained by the concerted activation of tissue-resident and circulating immune cells. Whether tissue-resident lymphocytes confer early antiviral immunity at local sites of primary infection prior to the initiation of circulating responses is not well understood. Furthermore, the kinetics of initial antiviral responses at sites of infection remain unclear. Here, we show that tissue-resident type 1 innate lymphoid cells (ILC1) serve an essential early role in host immunity through rapid production of interferon (IFN)-γ following viral infection. Ablation of Zfp683-dependent liver ILC1 lead to increased viral load in the presence of intact adaptive and innate immune cells critical for mouse cytomegalovirus (MCMV) clearance. Swift production of interleukin (IL)-12 by tissue-resident XCR1 conventional dendritic cells (cDC1) promoted ILC1 production of IFN-γ in a STAT4-dependent manner to limit early viral burden. Thus, ILC1 contribute an essential role in viral immunosurveillance at sites of initial infection in response to local cDC1-derived proinflammatory cytokines.

DOI10.1016/j.cell.2017.09.052
Alternate JournalCell
PubMed ID29056343
PubMed Central IDPMC5687850
Grant ListR01 AI100874 / AI / NIAID NIH HHS / United States
P30 CA008748 / CA / NCI NIH HHS / United States
T32 GM083937 / GM / NIGMS NIH HHS / United States
T32 GM007739 / GM / NIGMS NIH HHS / United States
R01 AI130043 / AI / NIAID NIH HHS / United States

Person Type: